Yes.
and data to population. we’re look in about emavusertib that So continued learn more at those
as as made that’s monotherapy. would to As strategy more It this We single with or that we’re expect data it from public, discussions and now have for of preclinical with we would where patients drug to very exactly works in where have FLTX clinical very mutation going spliceosome agent. FDA. data so a mechanism we of know a going a clear we action works as you our consistently result forward know
single over expressed also it’s also of Long the IRAKX not you monotherapy that of quite it’s it, the is not as has just the Half significant the much population population. remember amount, driver genetic a disease but the entire largest works, as that just other But in still AML/MDS spectrum, crap. this so half much monotherapy has in
relapsed/refractory agent on we’re again, looks active we’re drug planning with shot drug going and ought doing rifle populations this far So the genetic is be, in and FLTX to this go to to be single differentially where so spliceosome. what setting,
that combination we’re go think else, to going everybody that’s sense. what frontline For we makes because
AML, of care In standard the aza/ven. is
aza/ven comers, release Gilead, with more is frontline combination So recent emavusertib, mutation a MDS what I we magro are in going to say care all the little question doesn’t would have. standard from you with In of the open. matter go
of waiting but care what regimen study, clear aza/ven still is. We’re output for the not exactly that the of it’s standard
want would to. emavusertib also what clear it’s not add to So we
going to this for is what is long-term, to KOLs review at and generically that’s else be what this is was the strategy a comers, used and filter try to I But point, we everywhere So most drug. get and doing drug That going needed. out FLTX – and appropriate our we’re agent physicians going really figure makes helpful. no is spliceosome our go sense, engaging this that long answer. it’s hope it single was mutation, to frontline, all as wherever a
